
Aminoacids and derivatives
Amino acids are compounds with a structure based on an amino group (-NH₂) and a carboxyl group (-COOH), both attached to a central carbon atom. This structure makes them essential for the synthesis of proteins and other biomolecules. Their derivatives can have regulatory properties over metabolic processes and biological systems, with applications in nutrition, health, and regenerative medicine.
At CymitQuimica, we offer a wide range of amino acids and their derivatives, ideal for research and the formulation of bioactive products.
Found 12278 products of "Aminoacids and derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Glycine-13C
CAS:Controlled Product<p>Applications Labelled analogue of Glycine (G615990), a non-essential amino acid for human development. Glycine (G615990) is an inhibitory neurotransmitter in spinal cord, allosteric regulator of NMDA receptors.<br>References Scott, D., et al.: J. Neurosci., 21, 3063 (2001), Laube, B., et al.: Neuropharmacology, 47, 994 (2004), Papadakis, M., et al.: J. Biol. Chem., 279, 14703 (2004), Chen, P., et al.: Mol. Pharmacol., 67, 1470 (2005), Wolosker, H., et al.: Mol. Neurobiol., 36, 152 (2007),<br></p>Formula:C13CH5NO2Color and Shape:White PowderMolecular weight:76.062-(4-Fluorophenyl)-2-[4-(4-fluorophenyl)piperazin-1-yl]acetic acid
CAS:Molecular weight:332.351013183593753,3-Dimethoxybenzidine dihydrochloride
CAS:Purity:98.0%Color and Shape:Solid, solidMolecular weight:317.2099914550781(S)-Baclofen
CAS:Controlled Product<p>Applications S-Enantiomer of Baclofen. Specific GABA-B receptor agonist. Muscle relaxant (skeletal).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Ahuja, S., et al.: Anal. Profiles Drug Subs., 14, 527 (1985), Brogden, R.N., et al.: Drugs, 8,1 (1974)<br></p>Formula:C10H12ClNO2Color and Shape:NeatMolecular weight:213.661-[3-Chloro-5-(trifluoromethyl)pyrid-2-yl]-1,4-diazepane
CAS:Purity:98.0%Color and Shape:LiquidMolecular weight:279.69000244140625ε-Aminocaproic Acid-d10 Hydrochloride
CAS:Controlled Product<p>Applications Labelled ε-Aminocaproic Acid. Used in the preparatiom of esters of 6-aminohexanoic acid as antibacterial agents. EACA is reported to inhibit chymotrypsin, Factor VIIa, lysine carbo xy peptidase, plasmin, and plasminogen activator.<br>References Dolezal, P., et al.: Pharm. Res., 10, 1015 (1993), Vavrova, K., et al.: Curr. Med. Chem., 12, 2273 (2005), Holas, T., et al.: Bioorg. Med. Chem., 14, 7671 (2006),<br></p>Formula:C6H4D10ClNO2Color and Shape:NeatMolecular weight:177.71-(Phenoxypropyl)piperazine
CAS:Formula:C13H20N2OPurity:98.0%Color and Shape:SolidMolecular weight:220.316Succinyl Carnitine Chloride Salt
CAS:Controlled Product<p>Stability Very Very Hygroscopic<br>Applications A metabolic intermediate of L-Carnitine.<br>References Huffman, K. et al.: Diab. Care, 32, 1678 (2009);<br></p>Formula:C11H20NO6ClColor and Shape:NeatMolecular weight:297.73Lacosamide-d3
CAS:Controlled Product<p>Applications Labelled Lacosamide (L098500). Lacosamide is a medication used for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. Lacosamide is a potent anticonvulsant.<br>References Lees, G., et al.: Brain Res., 612, 190 (1993), Kuo, C., et al.: Mol. Pharmacol., 51, 1077 (1997), Barton, M., et al.: Epilepsy Res., 47, 217 (2001), Beyreuther, B., et al.: Eur. J. Pharmacol., 539, 64 (2006), Beyreuther, B., et al.: CNS Drug Rev., 13, 21 (2007)<br></p>Formula:C13D3H15N2O3Color and Shape:NeatMolecular weight:253.31Lauroylamide Propylbetaine
CAS:Controlled Product<p>Applications Lauroylamide Propylbetaine is used cosmetic and hair compositions of enhanced viscosity and clarity.<br>References Anon., et al.: Bull. Chem. Soc. Japan, 41, 1175 (1968),<br></p>Formula:C19H38N2O3Color and Shape:NeatMolecular weight:342.52Baclofen-d4
CAS:Controlled Product<p>Applications Specific GABA-B receptor agonist. Muscle relaxant (skeletal).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Ahuja, S., et al.: Anal. Profiles Drug Subs., 14, 527 (1985), Brogden, R.N., et al.: Drugs, 8,1 (1974)<br></p>Formula:C102H4H8ClNO2Color and Shape:Light BrownMolecular weight:217.69D,L-threo-Droxidopa-13C2,15N Hydrochloride
CAS:Controlled Product<p>Applications A labelled synthetic amino acid precursor of Norepinephrine (N674500). Antiparkinsonian.<br>References Bartholini, J., et al.: J. Pharmacol. Exp. Ther ., 193, 523 (1975), Kato, T., et al.: Biochem. Pharmacol., 36, 3051 (1987), Kawabata, A., et al.: Br J. Pharmacol., 111, 503 (1994),<br></p>Formula:C713C2H12Cl15NO5Color and Shape:NeatMolecular weight:252.63Tert-butyl 4-(5-hydroxypyrimidin-2-yl)piperazine-1-carboxylate
CAS:Purity:98%Molecular weight:280.3280029296875L-Tryptophan
CAS:<p>Applications Essential amino acid.<br>References Goze, C., et al.: Eur. J. Pharmacol., 643, 153 (2010), Bhandare, P., et al.: J. Chem. Pharm. Res., 2, 372 (2010),<br></p>Formula:C11H12N2O2Color and Shape:Off-WhiteMolecular weight:204.231-(5-Fluoropyridin-2-yl)-1,4-diazepane dihydrochloride
CAS:Purity:95.0%Molecular weight:268.16000366210945-Hydroxy L-Tryptophan
CAS:Controlled Product<p>Impurity L-5-Hydroxytryptophan(Tryptophan EP Impurity D)<br>Applications 5-Hydroxy-L-Tryptophan (L-5-Hydroxytryptophan(Tryptophan EP Impurity D)) is a hydroxylated metabolite of L-Tryptophan (T947210).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Gartside, S., et al.: Eur. J. Pharmacol., 179, 103 (1990); Gijsman, H., et al.: J. Clin. Psychopharmacol., 22, 183 (2002),; Schruers, K., et al.: Psychiatry Res., 113, 237 (2002);<br></p>Formula:C11H12N2O3Color and Shape:NeatMolecular weight:220.223-[(1-methyl-4-piperidinyl)oxy]-1-propanamine
CAS:Formula:C9H20N2OPurity:95.0%Color and Shape:LiquidMolecular weight:172.2725,7-Dihydroxy-4-methyl-3-(4-methylpiperazin-1-yl)-2H-chromen-2-one
CAS:Purity:95.0%Molecular weight:290.3190002441406

